Stock Market Today, Feb: ImmunityBio Up on Anktiva EU OK
ImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Zero Based Budgeting Myths explores common beliefs that can derail plans, offering fact-based clarifications and corrections.
15,604 articlesImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Lucid faces a pivotal year as production scales and capital needs rise. This guide outlines plausible paths for where...
As driverless taxis move from test zones to real streets, Alphabet and its Waymo unit sit at the center of the race. ...
A broad pullback in software stocks has created compelling opportunities for patient investors. Here are two names wi...
Three ETF filings aim to convert binary election outcomes into tradable funds, moving political bets from niche marke...
A wave of fresh analyst upgrades and price-target bumps hits NVIDIA, Alphabet, and other big names as markets start t...
A new AI-driven marketing platform is entering the market via a Reg A+ offering at $0.85 a share, aiming to mirror th...
Investors are watching Meta Platforms for a potential stock split. This guide explains how splits work, what they mea...
Planning to retire soon? A single year can shift the numbers dramatically. Here are three clear signs you should wait...
Bilt Rewards rolls out an AI-powered Neighborhood Concierge, enabling renters to pay rent, book amenities, and tap in...
D-Wave QBTS delivered a notable Q4 2025 run, with rising revenue and expanding services. This story breaks down what ...
Mortgage rates have shifted from stubborn highs to a window of lower financing costs. This article shows how investor...